Ewelina Wójcik

Ewelina is the Chief Research Officer at Proteon Pharmaceuticals where she manages a +40-person R&D Function. A scientist in the fields of Microbiology and Molecular Genetics, wrote her Ph.D. thesis on “Unusual DNA structures as endogenous mutagens in mycobacteria”. She is responsible for the scientific development of bacteriophage products (BAFASAL, BAFADOR, anti-Avian Pathogenic E. coli product, anti-Mastitis product, anti-Campylobacter product).

Ewelina has recently volunteered to work in the Coronovirus Diagnostic Center in Łódź, Poland which was established to increase efficacy in testing SARS Cov-2.